In contrast to the highlighted positive effects of SCFAs, the bacterial metabolite butyric acid plays a role in exacerbating ameloblastoma, a benign tumour of the jawbone, through interactions with epidermal growth factor and transforming growth factor β1 secreted by the tumour cells [114]. The gene discussed is EGF; the disease is neoplasm.